AMLX
Amylyx Pharmaceuticals Inc
32.40$
-4.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | |
| 834.4% | 3,783.7% | 18.2% | 13.5% | 6.7% | 48.2% | – | |
| -734.4% | -3,683.7% | 100.0% | 86.5% | 93.3% | 51.8% | – | |
| 834.4% | 3,783.7% | 15,452.6% | 420.4% | 33.7% | 119.1% | – | |
| 216.1% | 2,286.3% | 13,660.7% | 571.9% | 47.0% | 127.8% | – | |
| 950.5% | 2,317.1% | 29,013.3% | 992.3% | 83.1% | 412.0% | – | |
| -950.5% | -6,000.8% | -29,013.3% | -905.7% | 10.2% | -360.2% | – | |
| 89.5% | 352.0% | 12.6% | 19.3% | – | – | – | |
| -961.9% | -6,504.6% | -30,853.0% | -888.9% | 14.3% | -345.8% | – | |
| 77.1% | 393.4% | -18.2% | 3.5% | 1.3% | -0.4% | – | |
| -1,039.0% | -6,504.6% | -30,834.7% | -892.4% | 12.9% | -345.4% | – | |
| 78.1% | -6,000.6% | -28,995.1% | -903.5% | 14.5% | -333.0% | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.